D M Goldenberg - Concepedia

Author

D M Goldenberg

Center for Molecular Medicine and Immunology

Also Known As

D Goldenberg, D M Goldenberg, D. Goldenberg, D. M Goldenberg, D. M. Goldenberg, D.M. Goldenberg, DM Goldenberg, David M. Goldenberg, Goldenberg, Dolly

135

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Center for Molecular Medicine and Immunology University of Kentucky Immunomedics (United States)University of California, Los Angeles Harvard University

About

D M Goldenberg is an author at Center for Molecular Medicine and Immunology specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	43	2K
2	Health Sciences	8	8	564
3	Engineering	5	5	139
4	Allergy	4	4	158
5	Natural Sciences	1	1	18

D M Goldenberg

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. D M Goldenberg, E E Kim, F. H. DeLand, PubMed Radioactive AntibodiesOncologic ImagingPathologyTc Background RadioactivityTreatment Verification	1980	273
CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer D M Goldenberg, A. C. Carter, V. L. W. Go, Journal of Cancer Research and Clinical Oncology Tumor BiologyMedicineCancer ManagementPathologyCancer Biology	1981	127
Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. F. Moffat, Carl Pinsky, Luz Hammershaimb, Journal of Clinical Oncology	1996	126
Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. R M Sharkey, Cecilia Motta‐Hennessy, David Pawlyk, PubMed ImmunologyPathologyTumor/nontumor RatiosTumor UptakeTumor Biology	1990	105
Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma. E J Pawlak-Byczkowska, H. J. Hansen, Arnold S. Dion, PubMed Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmunotherapy	1989	88
Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. R M Sharkey, Florence Kaltovich, Lisa B. Shih, PubMed Immunocytochemical TechniqueImmunologyImmunotherapyOncologyGastrointestinal Oncology	1988	78
Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. F. James Primus, Sidney Bennett, E E Kim, PubMed CaprineImmunocytochemical TechniquePlasma RadioactivityImmunologyPathology	1980	74
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Robert M. Sharkey, Mark Pykett, J A Siegel, PubMed ImmunologyPathologyTumor TransplantationImmunotherapyTumor Biology	1987	67
LBA17 ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC) Aditya Bardia, Sara M. Tolaney, Delphine Loirat, Annals of Oncology Breast OncologyOncologyClinical TrialsBreast CancerLba17 Ascent	2020	64
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. Malik Juweid, Robert M. Sharkey, Thomas M. Behr, PubMed	1996	63

Page 1